good on any construction??, page-62

There may not be much to say on the oncology company actually. Maybe its better to wait until more details come out.

I will tidy up my previous comments around dilution though. i calculate dilution as:
- 30% to ACL
- 42% to Oncology Company

That assumes they raise 15m (7.5m IPO, 7.5m options) and i dont partake in the SPP. this needs to be validated once they tell us the details of the IPO though.

I was hoping for a 30% dilution but i can live with an average of 36%. I can buy a few more at these prices to reduce it further too. So not too bad.

Now we need to see great numbers from DRL and good news indicating that HA-Iri kills cancer stem cells. That will drive the share price for both fonda and oncology.